Rapid streptococcus A test Xpert® Xpress

for infectious diseasesfor DNAthroat

To accurately diagnose pharyngitis caused by Group A Streptococcus (GAS) due to increasing incidence and prevalence globally. Annually, 616 million people have GAS pharyngitis, more than 18.1 million people develop severe GAS disease and more than 517,000 people die due to severe GAS disease.1 Reduce overuse of antibiotics for the treatment of pharyngitis Literature shows 37% of children who presented with pharyngitis tested positive for GAS, however 56% of visits were associated with antibiotic prescriptions. Similarly, 18% of adults presented with pharyngitis caused by GAS, but 72% were treated with antibiotics. The Solution Careful selection of the target gene produces quality results. Delivering accurate and timely results optimizes fast treatment decisions and eliminates the need to perform culture confirmation of negative results. The Impact Accurate diagnosis of GAS supports antimicrobial stewardship initiatives and may reduce the amount of patients inappropriately prescribed antibiotics. May support testing efficiency and potential cost savings by reducing follow‑up culture testing in certain settings.3 In clinical practice, treating an infected person with an appropriate antibiotic generally prevents the spread of infection and reduces the risk of post‑infectious complications, such as rheumatic fever and acute glomerular nephritis.